Arlindo R. Ferreira

Professor Auxiliar Convidado

Generic Bio

Participação na FM-UCP

  • Unidade Curricular Crescimento e Desenvolvimento I

 

Áreas de atividade 

  • Cancro da Mama - Prática Clínica e Investigação Clínica

 

Atividade Profissional

  • Fundação Champalimaud, Médico Oncologista e Investigador Clínico
  • Universidade Católica Portuguesa, Faculdade de Medicina

 

Formação

  • Nov. 2015 - Out. 2020: Doutoramento em Medicina, Oncologia - Universidade de Lisboa, Faculdade de Medicina, Instituto de Medicina Molecular; Lisboa, Portugal 
  • Set. 2012 - Jun. 2015: Mestrado em Investigação Clínica e Assuntos Regulatórios de Medicamentos, Biologia e Dispositivos Médicos - Universidade Nova de Lisboa, Lisboa, Portugal e Northeastern University, Boston, EUA 
  • Fev. 2015 - Jun. 2015: CORe: Credential of Readiness - HBX | Harvard Business School, Boston, EUA 
  • Mar. 2012 - Dez. 2014: Formação em Investigação Clínica I e II - HMS | Harvard Medical School - Programa de Portugal, Boston, EUA 
  • Set. 2004 - Jul. 2010: Licenciatura em Medicina - Universidade de Lisboa, Lisboa, Portugal; Pontuação final 17,1 em 20. 

 

 

Resumo da carreira profissional

  • Mar. 2019 - presente: Médico Oncologista e Investigador Clínico na Fundação Champalimaud, Centro Clínico Champalimaud, Unidade de Mama 
  • Set. 2021 - presente: Professor assistente convidado na Universidade Católica Portuguesa, Faculdade Católica de Medicina 
  • Nov. 2018 - Fev. 2019: Investigador Clínico no Gustave Roussy - Cancer Campus, Villejuif, França 
  • Jan. 2012 - Nov. 2018: Médico Residente de Oncologia no Centro Hospitalar Lisboa Norte, Lisboa, Portugal 
  • Maio. 2017 - Jul. 2017: Bolseiro de Investigação Clínica no Institut Jules Bordet, Bruxelas, Bélgica 
  • Jul. 2014 - Set. 2015: Bolseiro de Investigação Clínica no Dana Farber Cancer Institute, Boston, EUA 
  • Jan. - Dez. 2011: Internato geral (Ano Comum / Ano de Internato) no Centro Hospitalar Lisboa Central, Lisboa, Portugal (Ano de internato da prática médica - Rotações em Medicina Interna, Oncologia Médica, Cirurgia Geral, Pediatria, Obstetrícia e Ginecologia, Medicina Familiar e Medicina de Saúde Pública).


Línguas

Português | Inglês

 

Outros Interesses

  • Investigação clínica
  • Ensaios clínicos
  • Investigação de resultados
  • Eficácia comparativa
  • Qualidade de vida 

 

Artigo

Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium

Arlindo R. Ferreira (with Mariana Brandão). 2024. Breast Cancer Research and Treatment
Artigo

ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

Arlindo R. Ferreira (with Vaz-Luis, I.). 2022. Annals of Oncology
Outras

Genomic and Transcriptomic Determinants of Resistance to CDK4/6 Inhibitors and Response to Combined Exemestane plus Everolimus and Palbociclib in Patients with Metastatic Hormone Receptor Positive Breast Cancer

Arlindo R. Ferreira (with Zañudo, J.G.T.). 2022. medRxiv
Artigo

Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study

Arlindo R. Ferreira (with Cardoso Borges, F.). 2022. Breast
Artigo

Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo - Neotarget Trial

Arlindo R. Ferreira (with Pinto, D.). 2022. Breast Care
Artigo

Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial

Arlindo R. Ferreira (with Arlindo R. Ferreira). 2021. European Journal of Cancer
Artigo

Breast cancer surgery with augmented reality

Arlindo R. Ferreira (with Pedro F. Gouveia). 2021. The Breast
Artigo

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants

Arlindo R. Ferreira (with Lambertini, M.). 2021. npj Breast Cancer
Artigo

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

Arlindo R. Ferreira (with Condorelli, M.). 2021. ESMO Open
Artigo

Use of mHealth to Increase Physical Activity Among Breast Cancer Survivors With Fatigue: Qualitative Exploration

Arlindo R. Ferreira (with Elise Martin). 2021. JMIR Cancer
Artigo

Body weight and return to work among survivors of early-stage breast cancer

Arlindo R. Ferreira (with Di Meglio, A.). 2020. ESMO Open
Artigo

Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study

Arlindo R. Ferreira (with Di Meglio, A.). 2020. Breast
Artigo

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study

Arlindo R. Ferreira (with Blondeaux, E.). 2020. ESMO Open
Artigo

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

Arlindo R. Ferreira (with Mariana Brandão). 2020. ESMO Open
Artigo

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases

Arlindo R. Ferreira (with Soraia Lobo-Martins). 2020. Cancers
Artigo

Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk

Arlindo R. Ferreira (with Pistilli, B.). 2020. Journal of Clinical Oncology
Outras

Use of mHealth to Increase Physical Activity Among Breast Cancer Survivors With Fatigue: Qualitative Exploration (Preprint)

Arlindo R. Ferreira (with Elise Martin). 2020.
Artigo

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis

Arlindo R. Ferreira (with A.R. Ferreira). 2019. Annals of Oncology
Artigo

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.

Arlindo R. Ferreira (with Lambertini M). 2019. Breast cancer research and treatment
Artigo

Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study

Arlindo R. Ferreira (with Ferreira, A.R.). 2019. Clinical Breast Cancer
Artigo

Levels of circulating fibroblast growth factor 23 (FGF23) and prognosis in cancer patients with bone metastases

Arlindo R. Ferreira (with Mansinho, A.). 2019. International Journal of Molecular Sciences
Artigo

Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

Arlindo R. Ferreira (with Otto Metzger‐Filho). 2019. The Oncologist
Artigo

Modelling cancer outcomes of bone metastatic patients: Combining survival data with N-Telopeptide of type i collagen (NTX) dynamics through joint models 01 Mathematical Sciences 0104 Statistics

Arlindo R. Ferreira (with Loureiro, H.). 2019. BMC Medical Informatics and Decision Making
Artigo

Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer

Arlindo R. Ferreira (with Vendrell, I.). 2018. Medicine (United States)
Artigo

Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer

Arlindo R. Ferreira (with Maurer, C.). 2018. Breast
Artigo

Neoadjuvant treatment of stage IIB/III triple negative breast cancer with cyclophosphamide, doxorubicin, and Cisplatin (CAP Regimen): A single arm, single center Phase II study (GBECAM 2008/02)

Arlindo R. Ferreira (with Ferreira, A.R.). 2018. Frontiers in Oncology
Artigo

Adjuvant zoledronic acid to treat breast cancer: not for all

Arlindo R. Ferreira (with Costa, L.). 2017. The Lancet Oncology
Artigo

Bone metastasis risk factors in breast cancer.

Arlindo R. Ferreira (with Pulido C). 2017.
Artigo

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.

Arlindo R. Ferreira 2017. Breast (Edinburgh, Scotland)
Artigo

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study

Arlindo R. Ferreira (with Lambertini, M.). 2017. Clinical Breast Cancer
Artigo

Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.

Arlindo R. Ferreira 2017. Annals of oncology : official journal of the European Society for Medical Oncology
Artigo

Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.

Arlindo R. Ferreira 2017. Cancer treatment reviews
Artigo

Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.

Arlindo R. Ferreira (with Ferreira AR). 2017.
Artigo

Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational study.

Arlindo R. Ferreira 2017. Breast (Edinburgh, Scotland)
Artigo

Dynamic modeling of bone metastasis, microenvironment and therapy

Arlindo R. Ferreira (with Rui Moura Coelho). 2016. Journal of Theoretical Biology
Artigo

Hypocalcemia in patients with metastatic bone disease treated with denosumab

Arlindo R. Ferreira (with André Mansinho). 2016. Ann. Joint
Artigo

Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?

Arlindo R. Ferreira 2016. International Journal of Molecular Sciences
Artigo

N-telopeptide of type I collagen long-term dynamics in breast cancer patients with bone metastases: Clinical outcomes and influence of extraskeletal metastases

Arlindo R. Ferreira (with Ferreira, A.R.). 2016. Oncologist
Artigo

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases

Arlindo R. Ferreira (with Arlindo Ferreira). 2016. Oncotarget
Artigo

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort study

Arlindo R. Ferreira (with Arlindo R. Ferreira). 2016. The Breast
Outras

Bone Metastases

Arlindo R. Ferreira (with Arlindo R. Ferreira). 2015. International Manual of Oncology Practice
Artigo

Bone remodeling markers and bone metastases: From cancer research to clinical implications

Arlindo R. Ferreira (with Arlindo Ferreira). 2015. BoneKEy Rep
Artigo

Nocturnal blood pressure dipping in acute ischemic stroke

Arlindo R. Ferreira (with Sargento-Freitas, J.). 2015. Acta Neurologica Scandinavica
Artigo

Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study

Arlindo R. Ferreira (with Lambertini, M.). 2015. Oncologist
Artigo

Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors

Arlindo R. Ferreira (with Matteo Lambertini). 2015. Expert Opinion on Biological Therapy
Outras

Prostate Cancer

Arlindo R. Ferreira (with Arlindo R. Ferreira). 2015. International Manual of Oncology Practice
Artigo

Treatment of early-stage HER2 breast cancer—an evolving field

Arlindo R. Ferreira (with Arlindo R Ferreira). 2015. ecancer